journal
Journals Journal of Clinical Psychophar...

Journal of Clinical Psychopharmacology

https://read.qxmd.com/read/38639427/microsampling-techniques-suitable-for-therapeutic-drug-monitoring-of-antipsychotics
#21
JOURNAL ARTICLE
Lisanne M Geers, Anton J M Loonen, Daniël J Touw
BACKGROUND: Therapeutic drug monitoring (TDM) of antipsychotics for dose titration or detection of noncompliance is not uncommon in daily practice. Normally, TDM implies measuring a drug concentration in venous blood samples. This technique is invasive and requires trained assistants and patients normally need to go to an outpatient clinic. Over the past decades, sensitivity of analytical equipment has improved leading to a growing interest in microsampling techniques. These techniques are minimally invasive, require a small volume (<100 μL), usually result in stable samples, and can be collected by the patient or a caregiver at home...
April 19, 2024: Journal of Clinical Psychopharmacology
https://read.qxmd.com/read/38635918/glucagon-like-peptide-1-receptor-agonists-in-psychiatry
#22
JOURNAL ARTICLE
Hubertus Himmerich, Susan L McElroy
No abstract text is available yet for this article.
April 19, 2024: Journal of Clinical Psychopharmacology
https://read.qxmd.com/read/38597410/a-case-of-tachyphylaxis-after-long-term-intravenous-racemic-ketamine-for-treatment-resistant-depression
#23
JOURNAL ARTICLE
Stefanie Cavalcanti, Olga A Lopez, Simon Kung, Jennifer L Vande Voort, Kristin Somers, Mark A Frye, Balwinder Singh
No abstract text is available yet for this article.
April 10, 2024: Journal of Clinical Psychopharmacology
https://read.qxmd.com/read/38597404/neurotoxicity-related-to-multidrug-association-a-case-report
#24
JOURNAL ARTICLE
Syrine Ben Hammamia, Fatma Ezzahra Jabri, Anis Belhadj, Fahd Khefacha, Ahmed Saidani, Faouzi Chebbi, Emna Gaies, Sameh Trabelsi
No abstract text is available yet for this article.
April 10, 2024: Journal of Clinical Psychopharmacology
https://read.qxmd.com/read/38597403/a-first-trimester-exposure-to-ketamine-and-esketamine-for-depression-a-case-report
#25
JOURNAL ARTICLE
Megan N Kummerlowe, Simon Kung, Katherine M Moore, Hannah K Betcher
No abstract text is available yet for this article.
April 10, 2024: Journal of Clinical Psychopharmacology
https://read.qxmd.com/read/38591793/managing-a-treatment-resistant-schizophrenia-spectrum-disorder-with-a-hormonal-twist-in-a-female-patient-a-case-report-of-a-progestin-only-pill
#26
JOURNAL ARTICLE
Mauro Scala, Paula Martínez Trapote, Roberto Rodriguez-Jimenez, Basilio Pecorino, Alessandro Serretti
No abstract text is available yet for this article.
April 9, 2024: Journal of Clinical Psychopharmacology
https://read.qxmd.com/read/38587363/fifty-nine-year-old-woman-with-concurrent-administration-of-cobicistat-and-dexamethasone-potentially-leading-to-mania-a-case-report
#27
JOURNAL ARTICLE
Gerald Cheng, Sunpreet Singh, Christopher Garabet, Mark Ard
No abstract text is available yet for this article.
April 8, 2024: Journal of Clinical Psychopharmacology
https://read.qxmd.com/read/38595145/can-slow-personalized-titration-using-c-reactive-protein-monitoring-decrease-the-high-rates-and-mortality-of-clozapine-associated-myocarditis-seen-in-some-countries-a-call-for-research
#28
JOURNAL ARTICLE
Jose de Leon
PURPOSE/BACKGROUND: The hypothesis that slower personalized titration may prevent clozapine-associated myocarditis and decrease the disproportion incidence of 3% found in Australia was not described in a recent Australian article in this journal. METHODS: Six countries in addition to Australia have published information suggesting a similar incidence of clozapine-associated myocarditis. On September 19, 2023, PubMed searches were updated for articles from the United States, Korea, Japan, Canada, New Zealand, and Turkey...
March 29, 2024: Journal of Clinical Psychopharmacology
https://read.qxmd.com/read/38551454/brexanolone-treatment-in-a-real-world-patient-population-a-case-series-and-pilot-feasibility-study-of-precision-neuroimaging
#29
JOURNAL ARTICLE
Meg Guard, Alyssa K Labonte, Molly Mendoza, Michael J Myers, Maida Duncan, Andrew T Drysdale, Emily Mukherji, Tahir Rahman, Mini Tandon, Jeannie C Kelly, Emily Cooke, Cynthia E Rogers, Shannon Lenze, Chad M Sylvester
PURPOSE/BACKGROUND: Brexanolone is approved for postpartum depression (PPD) by the United States Food and Drug Administration. Brexanolone has outperformed placebo in clinical trials, but less is known about the efficacy in real-world patients with complex social and medical histories. Furthermore, the impact of brexanolone on large-scale brain systems such as changes in functional connectivity (FC) is unknown. METHODS/PROCEDURES: We tracked changes in depressive symptoms across a diverse group of patients who received brexanolone at a large medical center...
March 29, 2024: Journal of Clinical Psychopharmacology
https://read.qxmd.com/read/38526521/not-all-mucosal-rashes-after-lamotrigine-are-stevens-johnson-syndrome-case-of-mycoplasma-pneumoniae-induced-rash-and-mucositis-and-review-of-differential-diagnosis
#30
JOURNAL ARTICLE
Connor Dean, Samantha Ongchuan, Sahil Munjal
No abstract text is available yet for this article.
March 26, 2024: Journal of Clinical Psychopharmacology
https://read.qxmd.com/read/38506608/venlafaxine-associated-rhabdomyolysis-a-literature-review
#31
JOURNAL ARTICLE
Jieru Ren, Ying Wang, Jing Nie, Lei Sun, Huina Wu, Yamei Li, Jiyong Wu
PURPOSE: This systematic review aimed to investigate the clinical manifestations and characteristics of venlafaxine-associated rhabdomyolysis. METHODS: A systematic search was conducted in PubMed, Elsevier, Science Direct, Embase, Springer Link, Wiley Online Library, CNKI, and Wanfang databases from the date of database inception to January 2023. Previously reported cases of venlafaxine-associated rhabdomyolysis were identified, and relevant data from these cases were collected for descriptive statistical analysis...
March 21, 2024: Journal of Clinical Psychopharmacology
https://read.qxmd.com/read/38497680/relapse-of-tardive-dyskinesia-following-successful-treatment-with-amantadine-a-case-report
#32
JOURNAL ARTICLE
Keisuke Kusudo, Hiroyuki Uchida, Yuki Okada, Kazunari Yoshida
No abstract text is available yet for this article.
March 18, 2024: Journal of Clinical Psychopharmacology
https://read.qxmd.com/read/38497566/severe-urinary-retention-associated-with-combined-treatment-with-escitalopram-and-quetiapine-a-case-report
#33
JOURNAL ARTICLE
Ibtissam Koubaa, Meryem Moustatia, Bouchra Oneib
No abstract text is available yet for this article.
March 18, 2024: Journal of Clinical Psychopharmacology
https://read.qxmd.com/read/38497565/n-acetylcysteine-for-trichotemnomania-in-an-adult-female-with-williams-syndrome
#34
JOURNAL ARTICLE
Hannah M Carroll, Christopher J McDougle, Robyn P Thom
No abstract text is available yet for this article.
March 18, 2024: Journal of Clinical Psychopharmacology
https://read.qxmd.com/read/38489596/multiple-medication-use-resulting-in-serotonin-syndrome-with-deprescribing-resulting-in-acute-dystonia
#35
JOURNAL ARTICLE
Greg Noe, Kaushal Shah, Margaret Cinderella, Sahil Munjal
No abstract text is available yet for this article.
March 18, 2024: Journal of Clinical Psychopharmacology
https://read.qxmd.com/read/38489598/existing-and-emerging-technologies-for-therapeutic-monitoring-of-lithium-a-scoping-review
#36
JOURNAL ARTICLE
Santiago Pedraza-Sanabria, Seetal Dodd, Luis Fernando Giraldo-Cadavid, Karen Whittingham, Rosa-Helena Bustos
BACKGROUND/PURPOSE: Lithium is an effective psychoactive drug. It has a narrow therapeutic margin, with subtherapeutic levels or intoxication commonly occurring. Therapeutic drug monitoring (TDM) of lithium has several barriers. This scoping review aims to describe and analyze existing and emerging technologies for lithium TDM and to describe the lithium quantification parameters (precision, accuracy, detection limit) attributed to each technology. METHOD: PubMed, Scopus, Web of Science, and Google Scholar were searched...
March 7, 2024: Journal of Clinical Psychopharmacology
https://read.qxmd.com/read/38489589/real-world-evidence-of-antipsychotic-monotherapy-versus-polypharmacy-in-the-treatment-of-schizophrenia-spectrum-disorders
#37
JOURNAL ARTICLE
Şükrü Alperen Korkmaz, Esra Koca, Özge Yılmaz, Tayfun Özbek, Muhammed Alperen Güçlü, Sadice Kızgın
PURPOSE/BACKGROUND: It is still not well known whether antipsychotic monotherapy versus polypharmacy differs in terms of efficacy in the emergency department (ED) utilization, presentation with agitation/aggression, and rehospitalization in schizophrenia spectrum disorders (SSD) patients. This study aimed to determine the effectiveness of antipsychotic monotherapy and polypharmacy for these outcomes in the real world. METHODS/PROCEDURES: The study was conducted with electronic health records of 669 SSD patients admitted to the ED...
March 5, 2024: Journal of Clinical Psychopharmacology
https://read.qxmd.com/read/38684049/depression-in-persons-with-epilepsy-lessons-from-case-review
#38
REVIEW
Kathryn Abell, Dorothy K Sit, Katherine L Wisner
BACKGROUND: Major depressive disorder is highly prevalent among persons with epilepsy (PWEs). Between 30% and 50% of PWEs suffer from depression. Many factors contribute to this prevalence, including the psychosocial impact of the diagnosis, restrictions on driving and certain types of work, and adverse effects associated with antiseizure medications. Without proper treatment, depressed PWEs have increased risks for suicide, strained relationships, lowered seizure control, and impairment in functioning...
May 2024: Journal of Clinical Psychopharmacology
https://read.qxmd.com/read/38684048/comparative-effectiveness-of-long-acting-injectable-versus-oral-antipsychotics-in-patients-with-schizophrenia-using-the-prevalent-new-user-design-and-subgroup-analyses
#39
COMPARATIVE STUDY
Yusuke Okada, Ken Inada, Manabu Akazawa
BACKGROUND: We compared the effectiveness of long-acting injectable antipsychotics (LAIs) and oral antipsychotics (OAs) in treating schizophrenia, focusing on whether the benefits of LAIs over OAs are evident even in the prevalent new user design and on effect heterogeneity. METHODS: We conducted a prevalent new user cohort study using 2 administrative claims databases in Japan. We included patients with schizophrenia initiated on LAIs and propensity score-matched patients on OA...
May 2024: Journal of Clinical Psychopharmacology
https://read.qxmd.com/read/38684047/discovering-the-potential-value-of-coenzyme-q10-as-an-adjuvant-treatment-in-patients-with-depression
#40
RANDOMIZED CONTROLLED TRIAL
Mahnam Majmasanaye, Maryam Mehrpooya, Hasan Amiri, Azadeh Eshraghi
PURPOSE/BACKGROUND: Depressive disorder or mental cold is the most common mental disorder, and depression exists all over the world and in all countries and cultures. The results of several studies have shown that using compounds with antioxidant properties has been fruitful in patients with depression. Coenzyme Q10 (CoQ10) is a fat-soluble antioxidant and exerts its antioxidant effect by directly neutralizing free radicals or reducing tocopherol and preventing the inhibition of mitochondrial activity because of oxidative stress...
May 2024: Journal of Clinical Psychopharmacology
journal
journal
28217
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.